Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

A special gel scaffold was made that speeds up wound healing and skin regeneration, even though it breaks down faster than expected.

The research found a new way to heal chronic skin ulcers by turning certain cells into skin tissue using specific factors.

Living Skin Equivalent transplantation helps heal ischemic non-healing wounds.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Hair from balding and non-balding areas regrows similarly on mice.

Transplanted baby mouse skin cells grew normal hair using a new, efficient method.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Transplanting small skin grafts can successfully repigment leukoderma.

The treatment improved hair color in most vitiligo patients without major side effects.

An HIV patient with IRIS had rare syphilis symptoms affecting skin, eyes, and nerves.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The method increases stem-like cells for better skin regeneration.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Engineered skin using stem cells and collagen sponge effectively healed and regenerated complex skin features in mice.